HIROSHI NAGANAWA
- Molecular Biology top 1%
- Organic Chemistry top 0.5%
- Pharmacology top 0.1%
- Biotechnology top 0.2%
- Oncology top 5%
- Co-authors
- TOMIO TAKEUCHIHAMAO UMEZAWAMASA HAMADAShinichi KondoHIRONOBU IINUMATAKAAKI AOYAGITOMOHISA TAKITAH. Nakamura
- Topics
- Microbial Natural Products and Biosynthesis (136 papers)Synthesis and Biological Activity (47 papers)Carbohydrate Chemistry and Synthesis (46 papers)
- Cited by
- PharmacologyBiotechnologyToxicology
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
HIROSHI NAGANAWA
324 papers receiving 7.3k citations
Peers
Comparison fields: 5 of 133
- Molecular Biology 4.1k
- Organic Chemistry 3.0k
- Pharmacology 3.0k
- Biotechnology 1.1k
- Oncology 958
Countries citing papers authored by HIROSHI NAGANAWA
This map shows the geographic impact of HIROSHI NAGANAWA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HIROSHI NAGANAWA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HIROSHI NAGANAWA more than expected).
Fields of papers citing papers by HIROSHI NAGANAWA
This network shows the impact of papers produced by HIROSHI NAGANAWA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HIROSHI NAGANAWA. The network helps show where HIROSHI NAGANAWA may publish in the future.
Co-authorship network of co-authors of HIROSHI NAGANAWA
This figure shows the co-authorship network connecting the top 25 collaborators of HIROSHI NAGANAWA. A scholar is included among the top collaborators of HIROSHI NAGANAWA based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with HIROSHI NAGANAWA. HIROSHI NAGANAWA is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 59 | |
| 2 | 45 | |
| 3 | 19 | |
| 4 | 8 | |
| 5 | 8 | |
| 6 | 14 | |
| 7 | 11 | |
| 8 | 23 | |
| 9 | 10 | |
| 10 | 34 | |
| 11 | 27 | |
| 12 | Bequinostatins A and B, new inhibitors of glutathione S-transferase, produced by Streptomyces sp. MI384-DF12. Production, isolation, structure determination and biological activities.:PRODUCTION, ISOLATION, STRUCTURE DETERMINATION AND BIOLOGICAL ACTIVITIES | 6 |
| 13 | 13 | |
| 14 | Anthracycline metabolites from Streptomyces violaceus A262. III. New anthracycline obelmycins produced by a variant strain SE2-2385.:III. NEW ANTHRACYCLINE OBELMYCINS PRODUCED BY A VARIANT STRAIN SE2-2385 | 2 |
| 15 | 83 | |
| 16 | 1 | |
| 17 | 219 | |
| 18 | 10 | |
| 19 | 8 | |
| 20 | 6 |
About HIROSHI NAGANAWA
HIROSHI NAGANAWA is a scholar working on Pharmacology, Toxicology and Microbiology, having authored 328 papers that have together received 7.8k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (136 papers), Synthesis and Biological Activity (47 papers) and Carbohydrate Chemistry and Synthesis (46 papers). The work is most often cited by research in Pharmacology (3.0k citations), Biotechnology (1.1k citations) and Toxicology (373 citations). HIROSHI NAGANAWA has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include TOMIO TAKEUCHI, HAMAO UMEZAWA, MASA HAMADA, Shinichi Kondo, HIRONOBU IINUMA, TAKAAKI AOYAGI, TOMOHISA TAKITA, H. Nakamura, Yoshikazu Takahashi and TSUTOMU SAWA. Their work appears in journals such as FEBS Letters, Antimicrobial Agents and Chemotherapy and The Journal of Organic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.